Galliprant RSS Authorised This medicine is authorised for use in the European Union grapiprant Medicine Veterinary Authorised
Page contentsPage contents Overview Product information Product details Authorisation details Assessment history News on Galliprant Topics Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Galliprant : EPAR - Summary for the publicReference Number: EMA/734836/2017 English (EN) (81.94 KB - PDF)First published: 06/02/2018 Last updated: 07/10/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View español (ES) (81.97 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View čeština (CS) (93.99 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View dansk (DA) (83.34 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View Deutsch (DE) (82.76 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View eesti keel (ET) (82.18 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View ελληνικά (EL) (93.76 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View français (FR) (82.44 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View hrvatski (HR) (92.27 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View íslenska (IS) (83.29 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View Gaeilge (GA) (83.57 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View italiano (IT) (82.29 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View latviešu valoda (LV) (94.29 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View magyar (HU) (94.15 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View Malti (MT) (95.95 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View Nederlands (NL) (82.05 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View norsk (NO) (82 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View polski (PL) (95.62 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View português (PT) (83.01 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View română (RO) (94.17 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View slovenčina (SK) (94.08 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View slovenščina (SL) (82.27 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View Suomi (FI) (81.54 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View svenska (SV) (82.05 KB - PDF) First published: 06/02/2018 Last updated: 06/02/2018 View Product information Galliprant : EPAR - Product Information English (EN) (81.49 KB - PDF)First published: 06/02/2018 Last updated: 07/10/2025 View Other languages (25) български (BG) (91.78 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View español (ES) (81.51 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View čeština (CS) (92.48 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View dansk (DA) (82.05 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Deutsch (DE) (81.72 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View eesti keel (ET) (81.22 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View ελληνικά (EL) (91.79 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View français (FR) (81.63 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View hrvatski (HR) (91.56 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View íslenska (IS) (81.52 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Gaeilge (GA) (81.36 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View italiano (IT) (81.76 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View latviešu valoda (LV) (92.14 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View lietuvių kalba (LT) (92.19 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View magyar (HU) (92.76 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Malti (MT) (93.86 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Nederlands (NL) (81.15 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View norsk (NO) (81.52 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View polski (PL) (93.22 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View português (PT) (82.53 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View română (RO) (91.73 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View slovenčina (SK) (81.75 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View slovenščina (SL) (81.76 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Suomi (FI) (81.11 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View svenska (SV) (81.47 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Latest procedure affecting product information: Galliprant : EPAR - All Authorised presentations English (EN) (81.94 KB - PDF)First published: 06/02/2018 Last updated: 07/10/2025 View Other languages (25) български (BG) (93.36 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View español (ES) (81.97 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View čeština (CS) (93.99 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View dansk (DA) (83.34 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Deutsch (DE) (82.76 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View eesti keel (ET) (82.18 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View ελληνικά (EL) (93.76 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View français (FR) (82.44 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View hrvatski (HR) (92.27 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View íslenska (IS) (83.29 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Gaeilge (GA) (83.57 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View italiano (IT) (82.29 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View latviešu valoda (LV) (94.29 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View lietuvių kalba (LT) (94.03 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View magyar (HU) (94.15 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Malti (MT) (95.95 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Nederlands (NL) (82.05 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View norsk (NO) (82 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View polski (PL) (95.62 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View português (PT) (83.01 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View română (RO) (94.17 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View slovenčina (SK) (94.08 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View slovenščina (SL) (82.27 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Suomi (FI) (81.54 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View svenska (SV) (82.05 KB - PDF) First published: 06/02/2018 Last updated: 07/10/2025 View Product details Name of medicine Galliprant Active substance grapiprant International non-proprietary name (INN) or common name grapiprant Pharmacotherapeutic groupOther antiinflammatory and antirheumatic agents, non-steroids Authorisation details EMA product number EMEA/V/C/004222 Assessment history Expand section Collapse section Changes since initial authorisation of medicine Galliprant : EPAR - Procedural steps taken and scientific information after authorisation English (EN) (81.94 KB - PDF)First published: 30/05/2018 Last updated: 07/10/2025 View Initial marketing authorisation documents Galliprant : EPAR - Public assessment reportAdopted Reference Number: EMA/747932/2017 English (EN) (81.49 KB - PDF)First published: 06/02/2018 Last updated: 07/10/2025 View CVMP summary of positive opinion for GalliprantAdopted Reference Number: EMA/CVMP/673968/017 English (EN) (69.13 KB - PDF)First published: 10/11/2017 Last updated: 10/11/2017 View News on Galliprant Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-17 July 202518/07/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 13-15 June 202316/06/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 21-22 March 202324/03/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 14-16 February 202317/02/2023 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 202320/01/2023 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 13-15 April 202116/04/2021 Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 8-10 December 202011/12/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 17-18 March 202020/03/2020 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 19-21 February 201922/02/2019 Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 7–9 November 201710/11/2017 Topics Medicines This page was last updated on 07/10/2025 Share this page